IPO registrations (S-1, F-1) · Registrants
Lomond Therapeutics Holdings, Inc.
- SEC CIK
- 1900520 · filings on EDGAR ↗
- Former names
- Venetian-1 Acquisition Corp. (2021–2024)
- Registration
- Form S-1, first filed 2024-11-27, last 2025-08-01; 1 initial registration, 4 amendments
- Outcome
- Withdrawal requested 2026-07-10
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- C/O LOMOND THERAPEUTICS HOLDINGS, INC., 8 THE GREEN STE 8490, Dover, DE 19901
- EIN
- 87-2959575
- EDGAR entity type
- operating
- Insiders and CEO pay
- Lomond Therapeutics Holdings, Inc. on the corporate pages
Offering terms
- Shares offered
- 32,673,624
- Lead underwriters
- of Contents
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: Lomond Therapeutics Holdings, Inc. EXACT (CIK (EXACT))
- SEC filer: Lomond Therapeutics Holdings, Inc. EXACT (CIK (EXACT))
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2024-11-27 | S-1 | S-1 (registration) | Lomond Therapeutics Holdings, Inc. | 0001213900-24-103445 ↗ |
| 2025-01-31 | S-1/A | S-1/A (amendment) | Lomond Therapeutics Holdings, Inc. | 0001213900-25-008902 ↗ |
| 2025-03-10 | S-1/A | S-1/A (amendment) | Lomond Therapeutics Holdings, Inc. | 0001213900-25-022311 ↗ |
| 2025-06-18 | S-1/A | S-1/A (amendment) | Lomond Therapeutics Holdings, Inc. | 0001213900-25-055292 ↗ |
| 2025-08-01 | S-1/A | S-1/A (amendment) | Lomond Therapeutics Holdings, Inc. | 0001213900-25-070684 ↗ |
| 2026-07-10 | RW | RW (withdrawal request) | Lomond Therapeutics Holdings, Inc. | 0001213900-26-076903 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-01 | S-1/A | registration statement | $3.20 | 32,673,624 | $104,555,596 | 1 | primary document; price sentence, shares headline, proceeds computed, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Jacobs Ian Seth | Director,Officer,TenPercentOwner; Other | President, CEO, CFO, Secretary | 2 | 2022–2024 | |
| Tompkins Mark N. | Director,TenPercentOwner; Other | 2 | 2022–2024 | ||
| Dukes Iain D. | Director,Officer | CEO and Chairman | 2 | 2024 | |
| Eilean Therapeutics, LLC | TenPercentOwner | 1 | 2024 | ||
| GORDON CARL L | Director | 2 | 2024 | ||
| ORBIMED ADVISORS LLC | Director | 2 | 2024 | ||
| OrbiMed Capital GP IX LLC | Director | 2 | 2024 | ||
| OrbiMed Capital GP VIII LLC | Director | 2 | 2024 | ||
| OrbiMed Capital GP VII LLC | Director | 2 | 2024 | ||
| Rodriguez Eddie | Director | 1 | 2024 | ||
| Savchuk Nikolay | Director,Officer | President and COO | 2 | 2024 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-11-18 | Lomond Therapeutics Holdings, Inc. | Pharmaceuticals | $63,915,492 | $53,915,492 | 28 | 2 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Lomond Therapeutics Holdings, Inc. | DE | Form D private offerings | CIK (EXACT) |
| SEC filer | Lomond Therapeutics Holdings, Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, DE first:
- Merus N.V. DE
- Prelude Therapeutics Inc DE
- NRX Pharmaceuticals, Inc. DE
- Applied Molecular Transport Inc. DE
- NovaCardia Inc CA
- MyoKardia, Inc. CA
- Bioquest Corp CA
- Regen BioPharma Inc CA
- Catalent, Inc. NJ
- Korro Bio, Inc. MA
In other datasets, the same topic (Health) in DE:
- Nonprofit: 1212 CORPORATION (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health